| Market Cap | 23.80M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -26.82M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -1.00% |
| Sales | 41.9M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -36.00% |
| Dividend | N/A | Price/Book | 1.16 | EPS next 5Y | - | 52W High Chg | -84.00% |
| Recommedations | - | Quick Ratio | 1.15 | Shares Outstanding | 39.82M | 52W Low Chg | 3,532.00% |
| Insider Own | 11.66% | ROA | -23.74% | Shares Float | 29.97M | Beta | 2.65 |
| Inst Own | 13.85% | ROE | -83.31% | Shares Shorted/Prior | 91.22K/205.20K | Price | 0.58 |
| Gross Margin | 41.71% | Profit Margin | -47.97% | Avg. Volume | 41,844 | Target Price | - |
| Oper. Margin | -61.12% | Earnings Date | Nov 14 | Volume | 50,855 | Change | -1.75% |
Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.